Literature DB >> 2533010

Fibreoptic laser laparoscopy.

J F Daniell.   

Abstract

Many gynaecologist are now doing more aggressive operative laparoscopic surgery. We feel that procedures which in the past required open laparotomy to be successfully performed, can now be done with fibreoptic laser energy. This chapter reviews our experiences with argon, KTP and Nd-YAG lasers for advanced laparoscopic surgery. We feel that these fibreoptic lasers allow us to obtain good results with less risk, shortened operating room time and with reduced difficulty during surgery. In this time of concern for cost containment in medicine, it seems reasonable for interested physicians to reduce costs without cutting corners or compromising patient care. Careful, intelligent, selective use of fibreoptic lasers as well as non-laser laparoscopic techniques in gynaecology may help in cost containment by allowing compatible results while avoiding major surgery with its concomitant expense, increased risks, morbidity and discomfort for patients. All forward-thinking gynaecologists should investigate the potential for fibreoptic laparoscopic laser surgery in their practices.

Entities:  

Mesh:

Year:  1989        PMID: 2533010     DOI: 10.1016/s0950-3552(89)80008-2

Source DB:  PubMed          Journal:  Baillieres Clin Obstet Gynaecol        ISSN: 0950-3552


  3 in total

Review 1.  Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea.

Authors:  M L Proctor; P M Latthe; C M Farquhar; K S Khan; N P Johnson
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

2.  The success of laser laparoscopy in the treatment of endometriosis: a two-step analysis.

Authors:  J D Paulson; R Borremeo; G Speck
Journal:  JSLS       Date:  2001 Jan-Mar       Impact factor: 2.172

3.  The treatment of mild endometriosis with laser laparoscopy: a two-step treatment analysis of patients whose primary therapy was successful.

Authors:  John D Paulson; Mounira Habli; Azer Alizade; Rita Borromeo
Journal:  JSLS       Date:  2006 Jan-Mar       Impact factor: 2.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.